Vast Population Base Of Elderly To Boost Active Pharmaceutical Ingredient Demand

By Author: Pramod Kumar
Total Articles: 99
Comment this article

According to the World Health Organization (WHO), ‘active pharmaceutical ingredient (API)’ refers to any substance or a blend of substances that is used in finished pharmaceutical products. These substances intend to furnish pharmacological activity in products used to diagnose, cure, mitigate, prevent, or treat diseases and items that have a direct effect in modifying, correcting, and restoring physiological functions in human beings. According to the U.S. Food and Drug Administration (USFDA), major steps or operations in an API production process include multi-step fermentation and chemical synthesis, testing, purification, labeling, drying, crystallization, packing, and milling.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/active-pharmaceutical-ingredient-api-market/report-sample

The surging demand for APIs can be primarily attributed to the booming geriatric population. Owing to this reason, the active pharmaceutical ingredient market size is expected to rise from about $190 billion in 2020 to around $300 billion by 2030. The World Population Ageing 2020 report estimates ...
... that the global population of people aged 65 years and above will reach around 1.5 billion by 2050. In 2020, the population of this age pool stood at 727 million. Due to a weak immune system, the elderly create a high demand for medicated drugs for treating different disorders and diseases.

Make an Enquiry Before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=active-pharmaceutical-ingredient-api-market

Nowadays, companies operating in the active pharmaceutical ingredient market are focusing on product launches to gain a competitive edge. For instance, in October 2019, Amneal Pharmaceuticals Inc. introduced a generic version of Invega extended-release tablets in four dosages: 9 mg, 6 mg, 3 mg, and 1.5 mg. Similarly, in June 2021, Bajaj Healthcare Ltd. launched Ivejaj, an anti-parasitic drug, which can be used to treat COVID infection. The company developed this formulation and API for Ivermectin through its in-house R&D team.

Pramod Kumar is a Digital Marketing Specialist at IG Transformation Partners, specializing in digital strategy, content marketing, and online brand positioning. He focuses on developing marketing initiatives that help organizations strengthen their digital presence and communicate their value effectively in competitive global markets. His expertise includes search engine optimization (SEO), LinkedIn marketing, B2B digital campaigns, market-driven content creation, and digital analytics. By combining strategic thinking with creative storytelling, he helps translate industry insights into compelling marketing content that engages audiences and supports business growth. At IG Transformation Partners, Pramod contributes to promoting thought leadership, digital transformation insights, and innovative solutions through targeted marketing strategies and data-driven digital campaigns.